Both protein S and protein C are dependent on vitamin K for their production and function. A deficiency of either one is associated with a tendency toward thrombosis. Protein S serves as a cofactor to enhance the anticoagulant effects of activated protein C. Slightly more than half of protein S is complexed with C4-binding protein and is inactive. Activated protein C in the presence of protein S rapidly inactivates factors V and VIII.
This test is done to differentiate acquired from congenital protein S deficiency. Congenital deficiency of protein S is associated with a high risk for thromboembolism. Acquired deficiency of protein S can be seen in various autoimmune disorders and inflammatory states owing to elevation of C4-binding protein. This protein forms an inactive complex with protein S. C4-binding protein levels should be determined in all patients who demonstrate a reduced level of protein S.
Males: 60%130% or 0.601.30 of normal activity
Females (younger than 50 years): 50%120% or 0.501.20 of normal activity
Newborns: 15%50% or 0.150.50 of normal activity
Draw a 5-mL venous blood sample with a tube sodium citrate (blue-topped tube). The two-tube method is used. Label the specimen with the patients name, date and time of collection, and test(s) ordered.
Keep the specimen capped and on ice. Place in a biohazard bag and take to the laboratory immediately.
Decreased values are associated with protein S deficiency. Familial protein S deficiency is associated with recurrent thrombosis. Abnormal plasma distribution of protein S occurs in functional protein S deficiency. In type I, free protein S is decreased, although the level of total protein may be normal; in type II, total protein is markedly reduced.
Hypercoagulable-state acquired protein S deficiency is found in:
Diabetic nephropathy
CKD caused by hypertension
Cerebral venous thrombosis
Coumarin-induced skin necrosis
DIC
Thrombotic thrombocytopenia purpura
Acute inflammation
Pretest Patient Care
Explain test purpose and procedure.
Follow guidelines in Chapter 1 for safe, effective, informed pretest care.
Posttest Patient Care
Review test results; report and record findings. Modify the nursing care plan as needed. Counsel the patient regarding abnormal findings; explain the need for possible follow-up testing and treatment. Monitor for thrombotic tendency.
Follow guidelines in Chapter 1 for safe, effective, informed posttest care.
The following factors cause decreased protein S:
Heparin therapy or specimen contaminated with heparin
Patient on unstable warfarin (Coumadin should be discontinued for 30 days for a true protein S determination)
Pregnancy
Contraceptives (oral)
First month of life
L-Asparaginase therapy
This test is not useful in diagnosing DIC.